Detection of in vitro interferon-γ and serum tumour necrosis factor-α in multidrug-resistant tuberculosis patients

Clinical and Experimental Immunology

Volumn 141, Issue 3, 2005, Pages 541-548

  Fortes, A ^a   Pereira, K ^a   Antas, P R Z ^a   Franken, C L M C ^b   Dalcolmo, M ^c   Ribeiro Carvalho, M M ^a   Cunha, K S ^d   Geluk, A ^b   Kritski, A ^e   Kolk, A ^f   Klatser, P ^a   Sarno, E N ^a   Ottenhoff, T H M ^b   Sampaio, Elizabeth Pereira ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Health Unit   (Brazil)

^d Hospital Raphael de Paula Souza   (Brazil)

^e FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^f ROYAL TROPICAL INSTITUTE   (Netherlands)

Author keywords

ESAT 6; IFN ; MDR TB; TNF ; Tuberculosis

Indexed keywords

CYTOKINE; ETHAMBUTOL; GAMMA INTERFERON; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TUBERCULOSIS;

ADULT; ANTIGENS, BACTERIAL; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; CELLS, CULTURED; FEMALE; HUMANS; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 23044488566     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02872.x     Document Type: Article

References (36)

1. Dye C, Williams BG. Criteria for the control of drug-resistant tuberculosis. Proc Natl Acad Sci USA 2000; 97:8180-5.
2. Loddenkemper R, Sagebiel D, Brendel A. Strategies against multidrug-resistant tuberculosis. Eur Respir J 2002; 36:66s-77.
3. Reechaipichitkul W. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen. Thailand Southeast Asian J Trop Med Public Health 2002; 33:570-4.
4. Pinto WP, Hadad DJ, Silva Telles MA et al. Tuberculosis and drug resistance among patients seen at an AIDS Reference Center in São Paulo. Brazil Int J Infect Dis 2001; 5:93-100.
5. Newport MJ, Huxley CM, Huston S et al. A mutation in the interferon-γ receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335:1941-9.
6. Ottenhoff THM, Verreck FAW, Lichtenauer-Kaligis EGR et al. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat Genet 2002; 32:97-105.
7. Roach DR, Bean AG, Demangel C et al. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 2002; 168:4620-7.
8. Keane J, Gershon S, Wise RP et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001; 345:1098-104.
9. Cole ST, Brosch R, Parkhill J et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393:537-44.
10. Harboe M, Oettinger T, Wiker HG et al. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 1996; 64:16-22.
11. Ulrichs T, Munk ME, Mollenfopf H et al. Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors. Eur J Immunol 1998; 28:3949-58.
12. Arend SM, Andersen P, van Meijaarden KE et al. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6kDa protein and culture filtrate protein 10. J Infect Dis 2000; 181:1850-4.
13. Lalvani A, Nagvenkar P, Udwadia Z et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban indians. J Infect Dis 2001; 183:469-77.
14. Vekemans J, Lienhardt C, Sillah JS et al. Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun 2001; 10:6554-7.
15. Cardoso FL, Antas PR, Milagres AS et al. T-cell responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 in Brazilian tuberculosis patients. Infect Immun 2002; 70:6707-14.
16. + T cell counts have impaired Th1 responses. J Immunol 1997; 158:492-500.
17. Tsuyuguchi I. Immunotherapy for MDR-TB (multi-drug resistant tuberculosis) - its feasibility. Kekkaku 1999; 74:479-91.
18. Lee J-S, Song C-H, Kim C-H et al. Profiles of IFN-γ and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis. Clin Exp Immunol 2002; 128:516-24.
19. Arend SM, Geluk A, Krista E et al. Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides. Infect Immun 2000; 68:3314-21.
20. Collart MA, Belin D, Vassalli JD et al. Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachetin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J Exp Med 1986; 164:2113-8.
21. Lee J-S, Song C-H, Lim J-H et al. The production of tumour necrosis factor-alpha is decreased in peripheral blood mononuclear cells from multidrug-resistant tuberculosis patients following stimulation with the 30-kDa antigen of Mycobacterium tuberculosis. Clin Exp Immunol 2003; 132:443-9.
22. Hirsch CS, Toossi Z, Vanham G et al. Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis. J Infect Dis 1999; 179:945-53.
23. Schaible UE, Winau F, Sieling PA et al. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat Med 2003; 9:1039-46.
24. Gil DP, León LG, Correa LI et al. Differential induction of apoptosis and necrosis in monocytes from patients with tuberculosis and healthy control subjects. J Infect Dis 2004; 189:2120-8.
25. Song C-H, Kim H-J, Park J-K et al. Depressed IL-12, but not IL-18 production in response to a 30- and 32-kDa mycobacterial antigen in patients with active pulmonary tuberculosis. Infect Immun 2000; 68:4477-84.
26. Dlugovitzky D, Bay ML, Rateni L et al. In vitro synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin-1 beta by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement. Scand J Immunol 1999; 49:210-7.
27. Jo E-K, Kim H-J, Lim J-H et al. Dysregulated production of interferon-γ, interleukin-4 and interleukin-6 in early tuberculosis patients in response to antigen 85B of Mycobacterium tuberculosis. Scand J Immunol 2000; 51:209-17.
28. Doherty TM, Demissie A, Olobo J et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 2002; 40:704-6.
29. Demissie A, Abebe M, Aseffa A et al. Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4 delta2. J Immunol 2004; 172:6938-43.
30. Flynn JL, Goldstein MM, Chan J et al. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995; 2:561-72.
31. Gomez-Reino JJ, Carmona L, Valverde VR et al. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 2003; 48:2122-7.
32. Donnely RP, Freeman SL, Hayes MP. Inibition of IL-10 expression by IFN-gamma up-regulates transcription of TNF-alpha in human monocytes. J Immunol 1995; 155:1420-7.
33. Vankayalapati R, Wizel B, Weis SE et al. Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis. Clin Infect Dis 2003; 36:24-8.
34. Ulrichs T, Anding P, Porchelli S et al. Increased numbers of ESAT-6-and purified protein derivative-specific gamma interferon-producing cells in subclinical and active tuberculosis infection. Infect Immun 2000; 68:6073-6.
35. Al-Attiyah R, Mustafa AS, Abal AT et al. Restoration of mycobacterial antigen-induced proliferation and interferon-γ responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. FEMS Immunol Med Microbiol 2003; 38:249-56.
36. Rad ME, Bifani P, Martin C et al. Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerg Infect Dis 2003; 9:838-45.